Youre still showing up
Substance use disorders are defined in part by continued use of substances despite negative consequences
M., Straka J
9% vs placebo, with effects on both fasting and postprandial glucose Cardiometabolic Improvement: Decreases in blood pressure, waist circumference, lipid fractions, and inflammatory biomarkers
Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimers disease
In some embodiments, the auris-acceptable penetration enhancer is a surfactant comprising an alkyl-glycoside wherein the alkyl-glycoside comprises a sugar linked to a hydrophobic alkyl (e.g., an alkyl comprising about 6 to about 25 carbon atoms) by an amide linkage, an amine linkage, a carbamate linkage, an ether linkage, a thioether linkage, an ester linkage, a thioester linkage, a glycosidic linkage, a thioglycosidic linkage, and/or a ureide linkage